Form 4: Guardant Health Director Tariq Musa Reports Stock Transactions

Director Tariq Musa reported the acquisition and disposal of Guardant Health, Inc. common stock and restricted stock units on May 15, 2024.

Summary

• On May 15, 2024, Tariq Musa, a director of Guardant Health, Inc., reported transactions involving the company's securities.
• Musa acquired 250 shares of common stock at a price of $0.
• Musa also disposed of 250 restricted stock units.
• Following these transactions, Musa directly owns 3,497 shares of common stock and 8,495 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock. It allows investors to monitor the actions of key individuals within Guardant Health.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring compliance with SEC regulations.
• Similar filings are made by executives and directors at companies like Exact Sciences (EXAS) and Illumina (ILMN), which are also in the genomic diagnostics space.
• The reported transactions are typical for executives receiving and managing equity compensation.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.
• It helps stakeholders understand the actions of key personnel within the company.

Key Dates